CELU · Celularity Inc

NasdaqHealthcareBiotechnology

Celularity Inc Is A Regenerative And Cellular Medicine Company Focused On Developing Placental-Derived Allogeneic Cell Therapies And Biomaterial Products For The Treatment Of Degenerative Diseases, Aging-Related Conditions, Cancer, And Immune Disorders. The Company Operates Through Three Segments: Cell Therapy, Degenerative Disease, And Biobanking. It Generates The Majority Of Its Revenue From The Degenerative Disease Segment.

HealthcareNasdaqUSLow Float

$1.11

+47.8% latest move

Price & move as of the most recent catalyst (Aug 25) — not a live quote.

FLOAT

7.1M

FREE FLOAT %

22%

SHARES O/S

32.4M

MARKET CAP

$47.7M

EXCHANGE

Nasdaq

COUNTRY

CELU Catalyst History

Exchange and Listing StatusMinimum Bid Price WarningAug 25, 2026 · 2:55pm ET

CELUCelularity Inc

Celularity Inc. Receives Nasdaq Notification for Non-Compliance with Listing Rule

Company notified of delayed filings of Quarterly Reports on Form 10-Q.

Be early on the next CELU spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →